Spek Tro Flu Oro

download Spek Tro Flu Oro

of 4

Transcript of Spek Tro Flu Oro

  • 8/12/2019 Spek Tro Flu Oro

    1/4

    Introduction

    Propranolol (PRO), amiloride (AMI) and dipyridamole (DIP)

    are widely used to treat several diseases. PRO and AMI1 are

    antihypertensive substances, whereas DIP1 is an antithrombotic

    agent. These components are classified as doping substances

    and have been included in a list of forbidden substances2 by the

    International Olympic Committee.

    The sensitivity of fluorescence spectrometry has enabled it to

    be a useful analytical tool for monitoring trace compounds of

    biochemical interest. However, when substances whose

    individual spectral profiles contain broad bands, which often

    overlap, must be determined simultaneously by

    spectrofluorometry, it would be difficult to select a pair ofexcitation and emission wavelengths which could permit the

    determination of one of them without any interference of the

    other. For such a reason, it is worth investigating new methods

    to solve this problem without resorting to expensive or time-

    consuming techniques.

    Several approaches, such as synchronous,3 derivative4

    fluorescence spectrometry as well as variable-angle

    fluorescence5 spectroscopy have been developed to overcome

    such problems without having to utilize time-consuming and

    expensive procedures. All of these methods are based on

    improving the selectivity of the coexisting components.

    Chemometric methods, such as factor analysis,610 have

    become even more popular in solving problems that are difficult

    to handle using conventional techniques, without having to

    resort to expensive or time-consuming procedures. Especially,

    three-way resolution and calibration methods1113 play important

    roles in solving the problem of closely overlapping fluorescence

    spectra. These methods utilize mathematical separation

    procedure to substitute the traditional chemical separation

    procedure, which is different from those.35 In addition, these

    approaches can not only determine the concentrations, but can

    also provide spectral profiles of the components in the mixtures.

    In this work, with both purposes, the present authors resolved

    mixtures of the aforementioned three doping substances with

    broad and highly overlapping excitation and emission spectra,

    using a newly proposed modified PARAFAC algorithm with a

    penalty digonalization error (PDE).14 One purpose is to solve

    the spectral overlapping problem and to further extend the

    applications of chemometric methods; another is to further

    demonstrate the characteristic features of the PDE algorithm.

    Theory

    Before using the PDE algorithm, a simple introduction to it

    should be presented. For details, the readers are recommended

    to Ref. 14.

    Trilinear model

    According to three-dimentional fluorometry, the trilinear

    model can be written as

    X..k= ckfafbft+ E..k k= 1, 2, 3, , K, (1)

    where F is the component number and K is the number of

    samples (mixtures); af, bf and cf are the emission, excitation and

    concentration profiles of thefth component. In matrix notation,

    the trilinear model can also be equivalent to the following three

    F

    f=1

    333ANALYTICAL SCIENCES MARCH 2002, VOL. 18

    2002 The Japan Society for Analytical Chemistry

    Spectrofluorometric Resolution of Closely Overlapping Drug

    Mixtures Using Chemometrics Methods

    Yu-Zhen CAO,*,** Cui-Yun MO,***Ji-gong LONG,**Hong CHEN,*Hai-Long WU,***andRu-Qin YU***

    *Key Laboratory of New Packaging Materials & Technology of China National Packaging Corporation,Zhuzhou Institute of Technology, Zhuzhou, 412008, China

    **Environmental Monitoring Central Station of Guangzhou City, NO. 95, Jixiang Road of Guangzhou City,Guangzhou, 510030, China

    ***College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, China

    A modified parallel factors analysis (PARAFAC) algorithm with a penalty diagonalization error (PDE), newly proposed

    by the present authors, was utilized to simultaneously resolve drug mixtures of propranolol (PRO), dipyridamole (DIP)

    and amiloride (AMI) without any loss of sensitivity. The analyses were performed in aqueous solution. The

    experimental results demonstrated that the profiles of the spectra and the concentrations could be accurately resolved

    using the PDE algorithm with a high sensitivity and stable repeatability. That is to say, the closely overlapping problem

    of the spectra could be easily solved. Furthermore, simultaneous determinations of three kinds of tablets, which contain

    PRO, AMI and DIP, respectively, were successfully performed with satisfactory results.

    (Received July 9, 2001; Accepted November 16, 2001)

    To whom correspondence should be addressed.

    E-mail: [email protected]

  • 8/12/2019 Spek Tro Flu Oro

    2/4

    equations:

    Xi.. = Bdiag(ai)Ct+ Ei.. i = 1, 2, ,I, (2)

    X.j. = Cdiag(bj)At+ E.j. j = 1, 2, ,J, (3)

    X..k= Adiag(ck)Bt+ E..k k= 1, 2, , K, (4)

    where I and J are the emission wavelength number and the

    excitation wavelength number, respectively.

    The algorithm

    From Eqs. (2) (4), one can obtain the following three

    equations for the diagonalization error:

    B+Xi..(C+)t diag(ai) = B+Ei..(C+)t, (5)

    C+X.j.(A+)t diag(bj) = C+E.j.(A+)t, (6)

    A+

    X..k(B+

    )t

    diag(ck) = A+

    E..k(B+

    )t

    . (7)

    By combining the diagonalization error with the PARAFAC

    error, one can obtain three objective functions, as follows:

    F(A) = ||Xi.. Bdiag(ai)Ct||F2 +||B+Xi..(C+)t diag(ai)||F2 , (8)

    F(B) = ||X.j. Cdiag(bj)At||F2 +||C+X.j.(A+)t diag(bj)||F2 , (9)

    F(C)= ||X..kAdiag(ck)Bt||F2 +||A+X..k(B+)tdiag(ck)||F2 . (10)

    From Eqs. (8) (10), one can acquire the following equations to

    express the factor matrices A, B and C:

    pi = diag[B+Xi..(C+)t], i = 1, 2, 3, ,I;

    P = [p1; p2; ;pI]; (11)

    A = ( X..kBdiag(ck) + P)(I + diag(ck)BtBdiag(ck))1; (12)

    qj = diag[C+X.j.(A+)t], j = 1, 2, 3, ,J;

    Q = [q1; q2; ;qJ]; (13)

    B = ( Xi..Cdiag(ai) + Q)(I + diag(ai)CtCdiag(ai))1; (14)

    rk= diag[A+

    X..k(B+

    )t

    ], k= 1, 2, 3, , K;

    R = [r1; r2; ;rK]; (15)

    C = ( X.j.Adiag(bj) + R)(I + diag(bj)AtAdiag(bj))1. (16)

    The PDE algorithm computes the loading matrix A using Eqs.

    (11) and (12) with B and C fixed; then, it fixes C and renews A

    to update B utilizing Eqs. (13) and (14); it finally calculates

    matrix C with the renewed A and the updated B according to

    Eqs. (15) and (16).

    Experimental

    Apparatus

    All of the fluorometric measurements were performed on an

    F-4500 fluorescence spectrophotometer (HITACHI).

    j

    j

    i

    i

    k

    k

    K

    k=1

    J

    j=1

    I

    i=1

    Reagents

    All of the experiments were performed with analytical

    reagent-grade chemicals, pure solvent and doubly distilled

    water. Stock solutions of PRO (The Fourth Pharmaceutical

    Factory of Changzhou; 25 mg dissolved in 100 ml of water),

    AMI (The Fourth Pharmaceutical Factory of Changzhou; 25 mg

    dissolved in 100 ml of water) and DIP (The Fourth

    Pharmaceutical Factory of Changzhou; 25 mg dissolved in 100

    ml of ethanol) were diluted to prepare working solutions by

    suitable dilutions using water. The stock solutions were stored

    and protected from light. Three kinds of tablets (Amiloride,

    Propranolol hydrochloride tablets and Persantin) containing

    AMI, PRO and DIP, respectively, with nominal contents, were

    randomly purchased from local pharmacies.

    Procedure

    The steady state fluorescence of 9 samples of the

    aforementioned three species was measured in aqueous solution.

    The concentrations of these species are listed in Table 1. The

    excitation wavelength was set from 220 nm to 320 nm at an

    interval of 4 nm, and the emission wavelength varied from 330

    nm to 522 nm with an interval of 4 nm. The scan rate was 1200

    nm/min. The effect of Rayleigh scattering was compensated by

    subtracting the measurement matrix of a blank from the sample

    measurements. Thus, a 49 26 9 data array was collected.This data array was treated using the PDE algorithm.

    In order to analyze three tablets containing PRO, AMI andDIP respectively, the authors combined the mixture of the three

    tablets with nine samples. The same treatment was made to

    these samples and the mixture. Thus a 49 26 10 data arraywas collected. The data array was resolved using the PDE

    algorithm.

    Results and Discussion

    Linear range

    The linear ranges of PRO, AMI and DIP were investigated

    before undertaking an experimental design. When PRO, AMI

    and DIP were, respectively, in the range of 9 100 ng/ml, 10

    150 ng/ml and 20

    110 ng/ml, the correlation coefficients were

    all above 0.9990.

    Resolution of profiles in three modes

    Figure 1 shows the resolved profiles using the PDE approach

    334 ANALYTICAL SCIENCES MARCH 2002, VOL. 18

    Table 1 Resolved concentrations with N = 3 and real

    concentrations of 9 samples (g/ml)

    a. MAE is defined as the mean absolute error.

    Sample

    1 0.0000 0.0387 0.0602 0.0005 0.0389 0.0638

    2 0.1044 0.0581 0.0602 0.1054 0.0553 0.0683

    3 0.0835 0.0387 0.0803 0.0863 0.0397 0.0708

    4 0.0626 0.0387 0.1004 0.0656 0.0416 0.0980

    5 0.0835 0.0581 0.0602 0.0826 0.0549 0.0707

    6 0.0626 0.0581 0.0803 0.0617 0.0524 0.0961

    7 0.0835 0.0387 0.0000 0.0796 0.0355 0.0018

    8 0.0626 0.0581 0.0000 0.0624 0.0530 0.0016

    9 0.0835 0.0000 0.0803 0.0819 0.0015 0.0652

    MAEa 0.0014 0.0025 0.0061

    Real Resolved

    AMI PRO DIP AMI PRO DIP

  • 8/12/2019 Spek Tro Flu Oro

    3/4

    withN= 3 and the actual ones of the PRO, AMI and DIP. The

    concentration profiles of 9 samples are listed in Table 1. These

    results are nearly the same as those of the true ones, which

    illustrates that the PDE algorithm will provide an accurate

    resolution of the substances that have seriously overlapping

    spectral profiles when the correct component number is used in

    the computation. The required iteration number for analyzing

    this data array was merely 18, and the required time was only 3

    s. These phenomena showed that the PDE algorithm was ableto recover the profiles of the data array accurately and rapidly,

    which are characteristic features of the PDE algorithm.14

    Figure 2 shows the resolved spectra of the data array using the

    PDE algorithm withN= 4, in which an excess component was

    used for the unknown background and the true profiles were

    plotted for a comparison. The concentration profiles of the

    three components of interest are listed in Table 2. These

    recovered results further illustrated that the PDE algorithm is

    insensitive for estimating the component number. That is to

    say, the PDE algorithm can provide accurate solutions provided

    that the number of factors used in a calculation is not less than

    that of the actual underlying factors, which is one of the

    characteristic features of the PDE approach.14

    Simultaneous determination of contents of three kinds of tablets

    Since the PDE algorithm was insensitive to estimating the

    component number, the present authors resolved a 49 26 10data array using the PDE algorithm with N = 4, in which an

    unknown background component was taken into consideration.

    With the concentrations of the nine samples (mixtures) known,

    the contents of three components were obtained using a second-

    order calibration. The experiment was performed in parallel

    four times; the calculated concentrations are given in Table 3.

    These results demonstrate that the PDE algorithm can be used to

    simultaneously determine practical samples of PRO, AMI andDIP with an unknown background.

    Conclusion

    In this paper, the newly proposed modified PARAFAC

    algorithm using a penalty diagonalization error (PDE) was used

    to resolve the system of propranolol (PRO), amiloride (AMI)

    and dipyridamole (DIP). The resolved results showed that the

    PDE approach could rapidly solve the problem of serious

    fluorescence spectral overlapping of the three components with

    an unknown background, and were insensitive to an estimation

    of the component number.

    Acknowledgements

    This work was financially supported by Natural Science

    335ANALYTICAL SCIENCES MARCH 2002, VOL. 18

    Fig. 1 Resolved spectra (solid lines) and true spectra (dotted lines)using the PDE algorithm with N= 3. (a) Excitation spectra and (b)

    emission spectra. Fig. 2 Recovered profiles (solid lines) and actual ones (dotted

    lines) in three modes utilizing the PDE algorithm with N = 4. (a)

    Excitation spectra and (b) emission spectra.

  • 8/12/2019 Spek Tro Flu Oro

    4/4

    Foundation of Hunan (Grant No. SSY2066) and the Key

    Laboratory of New Packaging Materials and Technology of

    China National Packaging Corporation.

    References

    1. A. C. Moffat, Clarkes Isolation and Identification of

    Drugs, 2nd ed., 1986, The Pharmaceutical Press, London,

    362, 363, 562, 563, 1037 and 1038.

    2. C. Rodrguez Burno, Dopaje, 1st ed., 1992, Mc-Graw

    Hill, Madrid.

    3. T. Vo-Dinh,Anal. Chem., 1978, 50, 396.

    4. P. John and I. Soutar,Anal. Chem., 1976, 48, 520.

    5. J. A. Murillo Pulgarn, A. Alann Molina, and P. F. Lpez,

    Anal. Chim. Acta, 1998, 370, 9.

    6. T. Adzuhata, J. Inotsume, T. Okamura, R. Kikuchi, T.

    Ozeki, M. Kajikawa, and N. Ogawa, Anal. Sci., 2001, 17,

    71.

    7. N. Yoshimura, M. Okazaki, and N. Nakagawa, Anal. Sci.,

    2000, 16, 1331.8. I. S. Scarminio, W. J. Barreto, D. N. Ishikawa, E. L.

    Paczkowski, and I. C. Arruda,Anal. Sci., 2000, 16, 1337.

    9. E. Forgacs and T. Cserhati,Anal. Sci., 1998, 14, 991.

    10. L. F. Capitan-Vallvey, N. Navas, R. Avidad, I. Deorbe, and

    J. J. Berzas-Navado,Anal. Sci., 1997, 13, 493.

    11. H.-L. Wu, Y.-Q. Feng, M. Shibukawa, and K. Oguma,

    Anal. Sci., 1997, 13, 99.

    12. H.-L. Wu, M. Shibukawa, and K. Oguma,Anal. Sci., 1997,

    13, 53.

    13. H.-L. Wu, K. Oguma, and R.-Q. Yu,Anal. Sci., 1994, 10,

    875.

    14. Y.-Z. Cao, Z.-P. Chen, C.-Y. Mo, H.-L. Wu, and R.-Q. Yu,

    Analyst, 2000, 125, 2303.

    336 ANALYTICAL SCIENCES MARCH 2002, VOL. 18

    Table 2 Recovered concentrations using the PDE algorithm

    with N= 4 (g/ml)

    a. MAE is defined as the mean absolute error.

    Sample

    1 0.0000 0.0387 0.0602 0.0010 0.0389 0.0637

    2 0.1044 0.0581 0.0602 0.1055 0.0554 0.0682

    3 0.0835 0.0387 0.0803 0.0859 0.0397 0.0707

    4 0.0626 0.0387 0.1004 0.0656 0.0416 0.0978

    5 0.0835 0.0581 0.0602 0.0828 0.0550 0.0708

    6 0.0626 0.0581 0.0803 0.0623 0.0524 0.0961

    7 0.0835 0.0387 0.0000 0.0798 0.0355 0.0017

    8 0.0626 0.0581 0.0000 0.0623 0.0532 0.0016

    9 0.0835 0.0000 0.0803 0.0821 0.0015 0.0653

    MAEa 0.0014 0.0025 0.0061

    Real Resolved

    AMI PRO DIP AMI PRO DIP

    Table 3 Calculated contents of three drugs for four parallel

    experiments (mg)

    Nominal contents 5 10 25

    First time 5.15 9.90 25.20Second time 5.12 9.89 25.34

    Third time 5.09 10.18 25.27

    Four time 4.97 10.20 25.29

    Mean values 5.08 10.04 25.28

    Amiloride (AMI) Propranolol (PRO) Persantin (DIP)